Biomarkers and prognostic factors 

Hepatocellular carcinoma : Molecular predictors of prevention of recurrence with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial

• Consult the Pubmed abstract

• To read more about “Hepatocellular carcinoma”

• Gut. 2019 Jun;68(6):1065-1075

Diffuse large B-cell lymphoma : NT-proBNP and cardiovascular score are accurate predictors of anthracycline-induced cardiotoxicity and can identify groups of patients at different risk

• Consult the Pubmed abstract

• To read more about “Diffuse large B-cell lymphoma”

• Eur J Haematol. 2019 Jun;102(6):509-515

Diffuse cutaneous systemic sclerosis: Progressive skin fibrosis is associated with a decline in lung function and worse survival in the European Scleroderma Trials and Research (EUSTAR) cohort

• Consult the Pubmed abstract

• To read more about “Diffuse cutaneous systemic sclerosis”

• Ann Rheum Dis. 2019 May;78(5):648-656.

X-linked hypophosphatemia: Utility of the radiographic Rickets Severity Score - higher values are associated with greater biochemical, clinical, and functional impairments

• Consult the Pubmed abstract

• To read more about “X-linked hypophosphatemia”

• Bone. 2019 May;122:76-81.

Systemic sclerosis: lung epithelial-derived surfactant protein D is a relevant diagnostic biomarker for systemic sclerosis-associated interstitial lung disease.

• Consult the Pubmed abstract

• To read more about “Systemic sclerosis”

• Arthritis Rheumatol. 2019 Jun;71(6):972-982.

Charcot-Marie-Tooth disease type 1A : Schwann cell transcript biomarkers

• Consult the Pubmed abstract

• To read more about “Charcot-Marie-Tooth disease type 1A”

• Ann Neurol. 2019 Jun;85(6):887-898

Oesophageal adenocarcinoma : A study within the National Cancer Institute Cohort Consortium assessed prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma

• Consult the Pubmed abstract

• To read more about “Oesophageal adenocarcinoma”

• Gut. 2019 Jun;68(6):960-968

Adrenocortical carcinoma : Fascin-1 is a novel prognostic biomarker associated with tumor invasiveness

• Consult the Pubmed abstract

• To read more about “Adrenocortical carcinoma”

• J Clin Endocrinol Metab. 2019 May 1;104(5):1712-1724

Hepatocellular Carcinoma : A large-scale multicenter study validates aldo-keto reductase family 1 member B10 as a prevalent serum marker

• Consult the Pubmed abstract

• To read more about “Hepatocellular carcinoma”

• Hepatology. 2019 Jun;69(6):2489-2501